GlassScriptPhysician profile
Angela Baker
NPI 1649851759
$1,555.52
in general payments reported to CMS, 2019-2025
17 companies · $562 in 2025
The $562 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $254 · 2022: $290 · 2023: $343 · 2024: $106 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $503.04 | 2021-2025 | Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $218.53 | 2021-2023 | Jardiance |
| Novo Nordisk INC | $197.97 | 2021-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $130.48 | 2023-2024 | Xarelto |
| Paratek Pharmaceuticals, INC. | $75.69 | 2021-2023 | Nuzyra |
| Abbott Laboratories | $66.92 | 2021-2023 | Freestyle Libre 3 |
| Pfizer INC. | $66.90 | 2022-2023 | |
| Amgen INC. | $40.92 | 2021-2022 | |
| Abbvie INC. | $40.46 | 2021-2023 | Teflaro |
| Exact Sciences Corporation | $37.88 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $35.17 | 2022-2025 | Mounjaro, Zepbound |
| Daiichi Sankyo INC. | $34.38 | 2021-2022 | |
| Dexcom, INC. | $32.50 | 2021-2022 | |
| Phadia US INC. | $24.25 | 2022 | |
| Inari Medical, INC. | $18.78 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.68 | 2024 | Lifevest |
| Gilead Sciences, INC. | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.